Mildly Elevated Liver Transaminase Levels: Causes and Evaluation - PubMed (original) (raw)
. 2017 Dec 1;96(11):709-715.
Affiliations
- PMID: 29431403
Free article
Mildly Elevated Liver Transaminase Levels: Causes and Evaluation
Robert C Oh et al. Am Fam Physician. 2017.
Free article
Abstract
Mild, asymptomatic elevations (less than five times the upper limit of normal) of alanine transaminase and aspartate transaminase levels are common in primary care. It is estimated that approximately 10% of the U.S. population has elevated transaminase levels. An approach based on the prevalence of diseases that cause asymptomatic transaminase elevations can help clinicians efficiently identify common and serious liver disease. The most common causes of elevated transaminase levels are nonalcoholic fatty liver disease and alcoholic liver disease. Uncommon causes include drug-induced liver injury, hepatitis B and C, and hereditary hemochromatosis. Rare causes include alpha1-antitrypsin deficiency, autoimmune hepatitis, and Wilson disease. Extrahepatic sources, such as thyroid disorders, celiac sprue, hemolysis, and muscle disorders, are also associated with mildly elevated transaminase levels. The initial evaluation should include an assessment for metabolic syndrome and insulin resistance (i.e., waist circumference, blood pressure, fasting lipid level, and fasting glucose or A1C level); a complete blood count with platelets; measurement of serum albumin, iron, total iron-binding capacity, and ferritin; and hepatitis C antibody and hepatitis B surface antigen testing. The nonalcoholic fatty liver disease fibrosis score and the alcoholic liver disease/nonalcoholic fatty liver disease index can be helpful in the evaluation of mildly elevated transaminase levels. If testing for common causes is consistent with nonalcoholic fatty liver disease and is otherwise unremarkable, a trial of lifestyle modification is appropriate. If the elevation persists, hepatic ultrasonography and further testing for uncommon causes should be considered.
Similar articles
- ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
Kwo PY, Cohen SM, Lim JK. Kwo PY, et al. Am J Gastroenterol. 2017 Jan;112(1):18-35. doi: 10.1038/ajg.2016.517. Epub 2016 Dec 20. Am J Gastroenterol. 2017. PMID: 27995906 - Causes and evaluation of mildly elevated liver transaminase levels.
Oh RC, Hustead TR. Oh RC, et al. Am Fam Physician. 2011 Nov 1;84(9):1003-8. Am Fam Physician. 2011. PMID: 22046940 - Elevated Liver Enzymes.
[No authors listed] [No authors listed] Am Fam Physician. 2017 Dec 1;96(11):Online. Am Fam Physician. 2017. PMID: 29431413 No abstract available. - Mildly elevated liver transaminase levels in the asymptomatic patient.
Giboney PT. Giboney PT. Am Fam Physician. 2005 Mar 15;71(6):1105-10. Am Fam Physician. 2005. PMID: 15791889 Review. - [Management of asymptomatic elevated serum aminotransferase levels, particularly in nonalcoholic steatohepatitis].
Oldenburg B, Van Berge Henegouwen GP. Oldenburg B, et al. Ned Tijdschr Geneeskd. 1999 Mar 6;143(10):506-9. Ned Tijdschr Geneeskd. 1999. PMID: 10321258 Review. Dutch.
Cited by
- Impact of obesity on clinical outcomes of methicillin-susceptible Staphylococcus aureus bloodstream infections.
Wasielewski AS, Casapao AM, Jankowski CA, Isache CL, Ravi M, Kunz Coyne AJ. Wasielewski AS, et al. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0075224. doi: 10.1128/aac.00752-24. Epub 2024 Sep 26. Antimicrob Agents Chemother. 2024. PMID: 39324801 - Prime Time or Lyme Time: A Case of Lyme Hepatitis in the Emergency Department.
Weis ME, Le D, Friel TJ, Carraro MN. Weis ME, et al. Cureus. 2024 Aug 12;16(8):e66713. doi: 10.7759/cureus.66713. eCollection 2024 Aug. Cureus. 2024. PMID: 39262528 Free PMC article. - In vitro Effect of Cannabidiol on Red Blood Cells: Implication in Long-Lasting Pathology Treatment.
Gómez CT, Borda N, Moscovicz F, Fernandez F, Lazarowski A, Auzmendi J. Gómez CT, et al. Curr Pharm Des. 2024;30(28):2222-2228. doi: 10.2174/0113816128287272240529072040. Curr Pharm Des. 2024. PMID: 38874045 - Effect of weight loss program using prebiotics and probiotics on body composition, physique, and metabolic products: longitudinal intervention study.
Hassan NE, El-Masry SA, El Shebini SM, Ahmed NH, Mehanna NS, Abdel Wahed MM, Amine D, Hashish A, Selim M, Afify MAS, Alian K. Hassan NE, et al. Sci Rep. 2024 May 14;14(1):10960. doi: 10.1038/s41598-024-61130-2. Sci Rep. 2024. PMID: 38744950 Free PMC article. - Influence of elevated liver enzyme level on 30-day mortality rates in patients undergoing nonemergency orthopedic surgery.
Liao TR, Lee YW, Chang CC, Liao AH, Lai YC, Liu CC. Liao TR, et al. Perioper Med (Lond). 2024 May 6;13(1):35. doi: 10.1186/s13741-024-00395-7. Perioper Med (Lond). 2024. PMID: 38711142 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical